Navigation Links
Lumenis(R) UltraPulse CO2 Laser to be Featured on National Television with Live Pearly Penile Papule (PPP) Procedure
Date:3/10/2009

Dr. William Groff will perform a PPP laser procedure on The Doctors national show, Tuesday, March 10, 2009. Check local listings for airtime.

SANTA CLARA, Calif., March 10 /PRNewswire/ -- Lumenis Ltd., a global developer, manufacturer and seller of laser, light-based and radio-frequency devices for surgical, aesthetic, and ophthalmic applications, announced that its UltraPulse CO2 laser will be featured on The Doctors national television show on Tuesday, March 10, 2009 as part of a live procedure performed by Dr. William Groff, a dermatologist with La Jolla Cosmetic Surgery Centre. Dr. Groff will treat Pearly Penile Papules (PPP), a condition in which small skin tags or domes form on the penis. Pearly Penile Papules (PPP) are very common and affect approximately 25% of men. PPP is not a sexually transmitted disease and is not contagious, however, it can be emotional disturbing and socially embarrassing, leading many men to seek treatment.

The cause of Pearly Penile Papules is unknown, although they are more common in men in their twenties and thirties and in men who are uncircumcised. PPP are often mistaken for genital warts and as a result, can cause stress and embarrassment.

The UltraPulse CO2 laser provides a quick, painless and permanent solution to PPP. The precision of UltraPulse allows exact vaporization of the papules without damaging the normal skin of the penis. There is no scarring and no loss of sensation and the recovery time is about 1 to 2 weeks.

"With more than 18 years of clinical experience, 34 FDA cleared indications and more than 90 peer-reviewed publications, the UltraPulse offers a safe and effective solution to men suffering from this condition," said Mr. Robert Mann, General Manager of Lumenis Global Aesthetics and Dermatology.

"While PPP is not a harmful condition, many men suffer embarrassment and humiliation in silence," said Dr. William Groff. "It is important for men to know that there is a safe, easy and effective solution."

About PPP

Pearly penile papules are small dome-shaped bumps that sometimes appear around the circumference of the penis. These bumps, or papules, are commonly skin-colored. Pearly penile papules, technically called hirsuties papillaris genitalis, are not sexually transmitted. Their cause is unknown, although they are more common in men in their twenties and thirties, and are also more common in uncircumcised males.

Some men choose to leave this condition untreated, as the papules are generally asymptomatic. However, many men find this condition to be embarrassing in intimate situations and suffer detrimental social and emotional effects from leaving the papules untreated.

Treatment for pearly penile papules is typically quite simple and effective through carbon dioxide laser treatment by a qualified dermatologist.

About Lumenis

Lumenis is Israel's largest medical device company with more than 800 employees worldwide. The Company invests heavily in R&D and holds a leading position in the markets in which it serves. Lumenis has over 250 patents worldwide, over 75 FDA clearances, worldwide presence in over 100 countries, and an installed base of over 70,000 systems. For more information about Lumenis and its products, log onto www.lumenis.com.

Lumenis(R) is a registered trademark of Lumenis Ltd.

UltraPulse(R) is a trademark of Lumenis Ltd.

    Contact:
    Michelle Maydan
    Director of Corporate Communications
    1-866-569-0597
    +972-4-959-9004
    e-mail: mmaydan@lumenis.com


'/>"/>
SOURCE Lumenis Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Lumenis(R) Introduces LightSheer(R) Duet(TM) for High Speed Permanent Hair Reduction
2. Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA
3. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
4. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
5. LCA-Vision New Excimer Laser Strategy to Reduce Operating Expenses in Excess of $3 Million Annually
6. New Laser Combo Therapy Zaps Acne
7. MedX Health Receives CE Mark for Laser & Light Products
8. State of the Art Cornea and Laser Vision Correction Practice Opens in Colorado
9. Acara Launches Laser Lipolysis Business Boosting Program
10. Laser Therapy Disappoints in Stroke Trial
11. Renaissance Laser & Vein Institute (LaserandVeinclinic.com) Provides Top Notch Varicose Vein Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the Federal ... an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at ... Committee (FOMC) dot charts are of interest to the press for their noise potential,” ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, Pfizer, and 3M ... to court documents and SEC filings. A jury has returned a verdict ... Optical Corporation, Case No. BC588866, Los Angeles County, California. The jury awarded $22.8 ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through its Connor Cares ... the Tamika Catchings Legacy Tour that will commemorate the Indiana Fever legend’s ... surfaces in all forms and levels of the game, Connor Sports has committed to ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is ... impact on long-term patient survival, reports a team of UPMC researchers in the ... in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent ... for drugs, biologics, consumer health and global clinical supply services, today announced two ... support the company’s continued investment and strategic growth plans in the Asia Pacific ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 25, 2016 Inivata, a ... of circulating tumour DNA (ctDNA) analysis to improve ... of Professor Clive Morris as Chief ... the clinical development programme, scientific collaborations, and through ... significant improvements in clinical outcomes for patients. ...
(Date:5/24/2016)... May 24, 2016   , ... non-inferiority in overall bowel cleansing and superiority in ... leansing of the ... ) , Norgine B.V. today announced new positive data ... and ascorbate bowel preparation) versus standard 2 litre PEG with ascorbate. ...
(Date:5/24/2016)... INDIANAPOLIS , May 24, 2016  Joe Marziani has joined VMS BioMarketing as ... chief executive officer, today. In his new role, Marziani will lead the company,s business ... care professionals to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
Breaking Medicine Technology: